Ushbu ish iqtibos qilgan ishlar

133 ta ish

Ish: Breast cancer vaccines; A comprehensive and updated review

Current and future burden of breast cancer: Global statistics for 2020 and 2040
Melina Arnold, Eileen Morgan, Harriet Rumgay +8
Maqola20228 iqtibos
ABI
Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
Nida Iqbal, Nida Iqbal, Naveed Iqbal +1
Sharh maqola20146 iqtibos
ABI
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao +3
Sharh maqola20236 iqtibos
ABI
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Sharh maqola20184 iqtibos
ABI
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng, Mia Spezia, Shifeng Huang +15
Sharh maqola20184 iqtibos
ABI
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies, Edward W. Roberts, Kelly Kersten +15
Sharh maqola20184 iqtibos
ABI
CTLA-4 and PD-1 Pathways
Elizabeth I. Buchbinder, Anupam M. Desai
Sharh maqola20153 iqtibos
ABI
Dendritic cell subsets in cancer immunity and tumor antigen sensing
Annalisa Del Prete, Valentina Salvi, Alessandra Soriani +4
Sharh maqola20233 iqtibos
ABI
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian +1
Sharh maqola20203 iqtibos
ABI
mRNA vaccines — a new era in vaccinology
Norbert Pardi, Michael J. Hogan, Frederick Porter +1
Sharh maqola20183 iqtibos
ABI
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Hans Raskov, Adile Orhan, Jan Pravsgaard Christensen +1
Sharh maqola20203 iqtibos
ABI
Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners
Marek Z. Wojtukiewicz, Magdalena M. Rek, Kamil Karpowicz +7
Sharh maqola20213 iqtibos
ABI
Targeting HER2-positive breast cancer: advances and future directions
Sandra M. Swain, Mythili Shastry, Erika Hamilton
Sharh maqola20223 iqtibos
ABI
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani‐Motlagh, Mehrnoush Ashja-Mahdavi, Angelica Loskog
Sharh maqola20202 iqtibos
ABI
Harnessing the immune system to improve cancer therapy
Nikos E. Papaioannou, Ourania V. Beniata, Panagiotis Vitsos +2
Sharh maqola20162 iqtibos
ABI
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Zaoqu Liu, Zhaokai Zhou, Qin Dang +4
Sharh maqola20222 iqtibos
ABI
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
Matthew D. Vesely, Robert D. Schreiber
Maqola20132 iqtibos
ABI
Biological subtypes of breast cancer: Prognostic and therapeutic implications
Özlem Yersal
Sharh maqola20142 iqtibos
ABI
CD28 and CTLA‐4 coreceptor expression and signal transduction
Christopher E. Rudd, Alison Taylor, Helga Schneider
Sharh maqola20092 iqtibos
ABI
Targeted therapies in breast cancer: New challenges to fight against resistance
Viviana Masoud, Gilles Pagès
Sharh maqola20172 iqtibos
ABI
Ex vivo pulsed dendritic cell vaccination against cancer
Yangzhuo Gu, Xing Zhao, Xiangrong Song
Sharh maqola20202 iqtibos
ABI
Cancer Vaccines, Adjuvants, and Delivery Systems
Samantha Paston, Victoria A. Brentville, Peter Symonds +1
Sharh maqola20212 iqtibos
ABI
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou +3
Sharh maqola20212 iqtibos
ABI
Recombinant nanobody against MUC1 tandem repeats inhibits growth, invasion, metastasis, and vascularization of spontaneous mouse mammary tumors
Parnaz Merikhian, Behrad Darvishi, Neda Jalili +10
Maqola20212 iqtibos
ABI
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud +13
Sharh maqola20222 iqtibos
ABI